spacer
home > ebr
PUBLICATIONS

European Biopharmaceutical Review

 

European Biopharmaceutical Review (EBR) is a journal designed to fill a unique position in scientific publishing. Published quarterly, it provides a dedicated platform of communication and information for the European biopharmaceutical market across Europe, North America, and the rest of the world.

With editorial consisting of in-depth articles, case studies, meetings, and report reviews written by specialists with hands-on experience in the biopharma industry; traditional multi-national pharma companies; investment houses; and industry-associated governmental, economic, and societal bodies. Each quarterly edition examines topical areas of importance across the board of biopharmaceutical research and development, with regular feature sections on BioBusiness Development, Research and Innovation, BioDiscovery, BioManufacturing plus special focusses on geographic or therapeutic territories.

For further information please contact:

Advertising
David Hirsh 

Editorial
Rema Farhan

 

Connect with us on Twitter: follow @EBRmagazine

Read our publications on the go in the Samedan app for phones and tablets. You can download issues for offline reading, and our archives go as far back as 2008! Download for free on the App Store, GooglePlay, or Amazon.

     


Click here to view the digital version of EBR


 


ebr
 
 
Featured in this issue
ATMPs and Immunoncology
Q&A: The Growth of Advanced Therapy Medicinal Products

A New Class of Innovation

eXmoor Pharma Conceptsí Dr Angela Obsorne talks to EBR about the promise of advanced therapy medicinal products and the impact of Brexit on the UK's approach to these.
Biomarkers and Personalised Medicine
Biomarkers for Rare Diseases

Jewel Biomarkers Can Be Found By Digging in the Right Mine

The future of biomarkers is bursting with potential, and surrogate biomarkers are now making way for the development of diagnostic, therapeutic, and prognostic biomarkers, enthuses Professor Hermann Mascher at pharm-analyt Labor.
  Biomarkers and Personalised Medicine
Biomarkers: The Promise of Personalised Medicine

The Road to Success

Dr Karen Hills and Professor Ken Smith at PredictImmune revisit the history of biomarkers and draw comparisons to more modern examples, demonstrating how biomarkers have become drivers for a more personalised approach to medicine.

spacer
Edited by
Dr Deborah O'Neil,
Chief Executive and Scientific Officer,
NovaBiotics Ltd
Published quarterly in
January, April,
July, and October

Widgets Magazine

Widgets Magazine
 

Widgets Magazine
Industry Events

PDA Europe Annual Meeting 2019

24 June 2019, Hilton Amsterdam

Featuring updates from international regulatory agencies as well as industry, this promises to become another highlight in the 2019 event calendar and is a meeting not to be missed!
More info >>

 
News and Press Releases

Registration Opens for Inaugural HPAPI USA Conference in October

The HPAPI global market is growing at an ever-increasing rate of CAGR at 8.6% that is projected to reach USD $31.56 Billion by 2025, with a significant segment market of HPAPI being oncology ADC which is at a CARG of a staggering 20%. The continual elevation of HPAPI potencies along with toxicity will further drive the needs for more cutting-edge containment solutions and best practices guidelines to ensure workers safety.
More info >>

air transport logo

 

White Papers

Finding the Right End-to-End Safety Solution for Your Needs

Bioclinica

With upcoming changes, including the implementation of the International Conference on Harmonisation (ICH) E2B(R3) Electronic Transmission of Individual Case Safety Report and Identification of Medicinal Products (IDMP) standards, the current state of safety reporting can be confusing. Your existing safety system may not be flexible enough to accommodate these changing regulations, which are still moving targets regarding the details needed for a comprehensive solution with the right level of processes, company-to-company integrations and finalized regional rules.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement